Immune checkpoint inhibitor-associated myocarditis and pericarditis: a pharmacovigilance study based on the FAERS database
Abstract Background Immune checkpoint inhibitors (ICIs) are medications used in cancer immunotherapy. However, treatment with ICIs may lead to adverse effects, particularly myocarditis and pericarditis. This practical pharmacovigilance study investigates the relationship between ICIs and myocarditis...
Saved in:
| Main Authors: | Guojing Yao, Yu Zhang, Haixia Zhang, Linlin Tang, Chuanhua Ding, Xueheng Zhou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | BMC Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12885-025-14668-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Top 10 drugs most frequently associated with adverse events of myocarditis and pericarditis
by: Jaehyeong Cho, et al.
Published: (2025-08-01) -
Drug-induced cardiac arrest: a pharmacovigilance study from 2004–2024 based on FAERS database
by: Gaocan Ren, et al.
Published: (2025-05-01) -
Risk assessment of the top 50 drugs associated with drug-induced orthostatic hypotension: a disproportionality analysis of the FAERS and JADER databases
by: Gaocan Ren, et al.
Published: (2025-03-01) -
Immune checkpoint Inhibitor related myocarditis reported through the FDA adverse event reporting system: pharmacovigilance trends in reporting and outcomes
by: David J. Reeves, et al.
Published: (2025-02-01) -
A real-world pharmacovigilance study of Certolizumab pegol based on FAERS database
by: Meng Liu, et al.
Published: (2025-08-01)